Past Awardees - Boston Investment Conference 2023

Your Impact

The Boston Investment Conference has fueled a decade of life-changing innovations at Boston Children’s. Thank you for your partnership.

2013 | Infant Brain Monitoring, Ellen Grant, MD

BabyMEG safely and accurately monitors infant brain activity.

Today: Physicians design improved seizure-treatment plans for babies.

2014 | Surgical Simulation, Peter Weinstock, MD, PhD

3D models of each patient’s unique physiology help neurosurgeons tackle the most complex procedures.

Today: Augmented and virtual reality tools expand our global reach.

2015 | Cancer Diagnosis, Mark Fleming, MD, DPhil

The Laboratory for Molecular Pediatric Pathology deploys next-generation sequencing technology.

Today: Experts accurately diagnose cancers and detect cancer-driving gene fusions.

2016 | Mitochondrial Therapy, James McCully, PhD

Healthy mitochondria restore damaged heart tissue.

Today: Mitochondrial therapy is tested in cancer, heart attack and diabetes.

2017 | Blood Stem Cells, Len Zon, MD

Patient-specific blood stem cells are created to treat rare disorders.

Today: Novel drug candidates are screened to accelerate blood stem cell production and bring them to the clinic.

2018 | Gene Therapy, Alessandra Biffi, MD

Stem cells delivered directly to the brain accelerate production of genetically corrected cells.

Today: New treatments for neurological disorders promise to change lives of millions worldwide.

2019 | Customized Therapy, Timothy Yu, MD, PhD

A therapy is created specifically for one child with a rare disease.

Today: Revolutionary thinking about a tailored treatment for a single patient creates hope for thousands worldwide.

2020 | COVID-19 Vaccine, Ofer Levy, MD, PhD

Researchers seek to optimize a coronavirus vaccine for older adults.

Today: Vaccine manufacturers adopt the basic science and advance projects to clinical trials.

2021 | Epilepsy Genetics, Ann Poduri, MD, MPH

Zebrafish models help scientists assess epilepsy drug candidates.

Today: Patients are matched with therapies that target the underlying cause of their epilepsy.

2022 | CAR-T Therapy, Roberto Chiarle, MD

Human trials will test powerful personalized treatment for deadly childhood cancer.

2021 Epilepsy Genetics

With the support of BIC, Annapurna Poduri, MD, MPH, is pioneering research that is radically changing how epilepsy is diagnosed and treated by bringing cutting-edge science to vast numbers of patients at Boston Children’s and far beyond.

2019 Rare Disease

175 million children worldwide suffer from a rare disease—conditions that will kill 30% of them before age 5. Proceeds will help Dr. Timothy Yu develop a revolutionary protocol for patient individualized treatments for rare disease.

2017 Curing Blood Disorders

Proceeds are accelerating groundbreaking blood stem cell research towards the clinic, where it will treat patients with leukemia, sickle cell disease, and other life-threatening blood disorders.

2015 Laboratory for Molecular Pediatric Pathology

Established a cutting-edge laboratory to unlock the potential of genomics to better diagnose and target treatments for children with cancer.

2013 BabyMEG

With BIC support, Dr. Ellen Grant invented the BabyMEG system to safely and accurately monitor infant brain activity.

2020 COVID-19

An authority on vaccine development, Ofer Levy, MD, PhD, director, Boston Children’s Precision Vaccines Program (PVP), is diligently working to protect the most vulnerable from the novel coronavirus using precision immunology.

2018 Gene Therapy

Proceeds are supporting the work of Alessandra Biffi, MD, the director of our gene therapy program and a world-renowned expert in the treatment of rare neurological diseases.

2016 Mitochondrial Transplantation

Revolutionary technique rescues hearts by transfusing the patient’s own healthy mitochondria into damaged cardiac muscle, restoring heart function and saving lives.

2014 Surgical Simulation

With BIC support, Dr. Peter Weinstock develops a pioneering approach to practicing neurosurgery through the use of 3D models of each patient’s unique physiology.

2012 Breakthrough Research

Proceeds supported cutting edge research in areas such as ultra-early cancer detection, robotic surgery, informatics and stem cells.